Nabriva Therapeutics to Report Third-Quarter 2019 Financial Results on November 12, 2019
DUBLIN, Ireland, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that …